Back to search

Article

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis

2024-04-30

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF) is a devastating pulmonary disease with no curative treatment other than lung transplantation. IPF results from maladaptive responses to lung epithelial injury, but the underlying mechanisms remain unclear. Here, we show that deficiency in the innate immune receptor, toll-like receptor 5 (TLR5), is associated with IPF in humans and with increased susceptibility to epithelial inj...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f86cd5ce-7e3a-5b5e-aa9f-4c2e722af1e8
DOI
10.1101/2024.04.30.591719
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisDOI 10.1101/2024.04.30.591719
Select a neighboring publication to make it the new centre.